Thank you to Reviewers.
- Published in:
- Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 2, p. 159, doi. 10.1177/1078155218756521
- Publication type:
- Article
Works matching IS 10781552 AND DT 2018 AND VI 24 AND IP 2
Results: 14
1
2
Rare incidence of tumor lysis syndrome in metastatic prostate cancer following treatment with docetaxel.
- Published in:
- Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 2, p. 153, doi. 10.1177/1078155217694492
- By:
- Publication type:
- Article
3
Potential cost savings by dose down-rounding of monoclonal antibodies in a community cancer center.
- Published in:
- Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 2, p. 116, doi. 10.1177/1078155217692400
- By:
- Publication type:
- Article
4
Experience with dasatinib and nilotinib use in pregnancy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 2, p. 121, doi. 10.1177/1078155217692399
- By:
- Publication type:
- Article
5
Pepsi® or Coke®? Influence of acid on dasatinib absorption.
- Published in:
- Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 2, p. 156, doi. 10.1177/1078155217692152
- By:
- Publication type:
- Article
6
Pharmacological management of anticancer agent extravasation: A single institutional guideline.
- Published in:
- Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 2, p. 129, doi. 10.1177/1078155217690924
- By:
- Publication type:
- Article
7
Adenocarcinoma of the appendix occurring in a patient treated with paclitaxel for locally advanced esophageal cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 2, p. 150, doi. 10.1177/1078155217689947
- By:
- Publication type:
- Article
8
A case report of enzalutamide administration in a dialysis-dependent patient with castration-resistant prostate cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 2, p. 143, doi. 10.1177/1078155216689381
- By:
- Publication type:
- Article
9
Pembrolizumab-induced myasthenia gravis: A fatal case report.
- Published in:
- Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 2, p. 146, doi. 10.1177/1078155216687389
- By:
- Publication type:
- Article
10
Back to life with checkpoint inhibitors in Hodgkin lymphoma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 2, p. 139, doi. 10.1177/1078155216685166
- By:
- Publication type:
- Article
11
Drug–drug interactions in patients receiving tyrosine kinase inhibitors.
- Published in:
- Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 2, p. 110, doi. 10.1177/1078155216682311
- By:
- Publication type:
- Article
12
Prevention of carboplatin-induced hypersensitivity reactions in women with ovarian cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 2, p. 83, doi. 10.1177/1078155216679028
- By:
- Publication type:
- Article
13
Surface contamination of hazardous drug pharmacy storage bins and pharmacy distributor shipping containers.
- Published in:
- Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 2, p. 91, doi. 10.1177/1078155216679027
- By:
- Publication type:
- Article
14
Patient perspectives on the barriers associated with medication adherence to oral chemotherapy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 2, p. 98, doi. 10.1177/1078155216679026
- By:
- Publication type:
- Article